H95.0
Recurrent cholesteatoma of postmastoidectomy cavity
Clinical Classification Guidelines
Medical Intelligence & Overview
Recurrent cholesteatoma of the postmastoidectomy cavity is a condition characterized by the abnormal growth of keratinizing squamous epithelium into the space created after mastoidectomy surgery. This condition can lead to hearing loss, infections, and damage to surrounding structures if not properly managed. It is a distinctive challenge in otology, requiring ongoing monitoring and tailored treatment approaches to prevent complications.
Causes & Symptoms
Clinical Causes: Incomplete removal of cholesteatoma tissue during initial surgery Re-growth of keratinizing epithelium in the post-surgical cavity Residual dead space in the mastoid area where epithelial tissue can proliferate Chronic ear infections leading to epithelial migration and growth Structural abnormalities in the middle ear or mastoid region that predispose to epithelial accumulation
Key Symptoms: Persistent or recurrent ear discharge (otorrhea) Hearing loss, which may be gradual or sudden Ear fullness or sensation of pressure Occasional pain or discomfort in the affected ear Recurrent infections in the postmastoidectomy cavity Unpleasant odor emanating from the ear Dizziness or balance disturbances in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of patient history, clinical examination, and imaging studies. Otoscopic inspection may reveal an abnormal growth or debris in the postmastoidectomy cavity. Imaging modalities like high-resolution CT scans help visualize bony erosion or soft tissue in the mastoid area. Audiometric testing assesses hearing status, and sometimes, biopsy or surgical exploration is necessary for definitive diagnosis.
Treatment Protocols: Managing recurrent cholesteatoma typically requires surgical intervention aimed at complete removal of the cholesteatoma tissue. Surgical options include revisiting the mastoid cavity to excise the new growth and repairing the affected structures to prevent further recurrence. Postoperative care involves regular follow-up with audiological assessments and imaging to monitor for potential recurrence. In some cases, medical management with antibiotics or steroids may be used to control infections or inflammation, but surgery remains the mainstay of treatment.
Clinical Advice & FAQs
Billing Guidance
Is H95.0 a billable ICD-10 code?
Yes, H95.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H95.0?
Clinical documentation must specify the nature of Recurrent cholesteatoma of postmastoidectomy cavity and any associated comorbidities for accurate reporting.
Cite this Clinical Reference